If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
We present the case of a 57-year-old woman with a history of hilar cholangiocarcinoma
type 3A of the Bismuth classification. A right hepatectomy after right portal embolization
was planned. Finally, because peritoneal carcinomatosis was diagnosed during surgery,
a palliative strategy was decided. Two uncovered metallic biliary stents (left and
right hepatic ducts) were placed, and chemotherapy was started. Four months later,
percutaneous placement of another metallic stent was necessary because of stent occlusion.
Four months later, she was readmitted because of acute cholangitis resulting from
stent re-occlusion. We used radiofrequency ablation for its recanalization (Video 1, available online at www.giejournal.org). After ERCP confirmed tumor ingrowth into the stent (Fig. 1A), a endobiliary radiofrequency ablation (RFA) catheter (Habib, EndoHPB, EMCision,
London, UK) was inserted through the endoscope on a 0.035-inch guidewire. The distal
tip of the catheter with the 2 electrodes was advanced through the stenosis under
fluoroscopic guidance. Two RFA applications were performed (bipolar coagulation mode,
maximum 10 W, 90 seconds). Necrotic debris was extracted by use of a balloon catheter.
Stent clearance was confirmed by cholangiography (Fig. 1B) and tomography. Chemotherapy was resumed, and no further obstruction of the stent
occurred during the following 6 months. Unfortunately, during follow-up, the patient
died, but not of a biliary adverse event. This case illustrates the potential benefit
and ease of use of endobiliary RFA for stent recanalization. Nevertheless, a cost-effectiveness
analysis is warranted.